MIT1



MIT1

A1AA1V2VV2I3II3T4TT4G5GG5A6AA6C7CC7E8EE8R9RR9D10DD10L11LL11Q12QQ12C13CC13G14GG14K15KK15G16GG16T17TT17C18CC18C19CC19A20AA20V21VV21S22SS22L23LL23W24WW24I25II25K26KK26S27SS27V28VV28R29RR29V30VV30C31CC31T32TT32P33PP33V34VV34G35GG35T36TT36S37SS37G38GG38E39EE39D40DD40C41CC41H42HH42P43PP43A44AA44S45SS45H46HH46K47KK47... and 34 more residue(s)...... and 34 more residue(s)

SMILES None
InChIKey None
Sequence AVITGACERDLQCGKGTCCAVSLWIKSVRVCTPVGTSGEDCHPASHKIPFSGQRMHHTCPCAPNLACVQTSPKKFKCLSKS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

MIT1

A1AA1V2VV2I3II3T4TT4G5GG5A6AA6C7CC7E8EE8R9RR9D10DD10L11LL11Q12QQ12C13CC13G14GG14K15KK15G16GG16T17TT17C18CC18C19CC19A20AA20V21VV21S22SS22L23LL23W24WW24I25II25K26KK26S27SS27V28VV28R29RR29V30VV30C31CC31T32TT32P33PP33V34VV34G35GG35T36TT36S37SS37G38GG38E39EE39D40DD40C41CC41H42HH42P43PP43A44AA44S45SS45H46HH46K47KK47... and 34 more residue(s)...... and 34 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.